Cite
HARVARD Citation
Reckamp, K. et al. (n.d.). Phase II trial of afatinib in patients with EGFR-mutated solid tumors excluding lung cancer: results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. European journal of cancer. pp. S84-S85. [Online].